Profile

Christopher Y. Thomas, M.D.Wake Forest Baptist Health

Christopher Y. Thomas, M.D.

Associate Professor,

Clinical Specialties

Genitourinary Oncology

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Email: cythomas@wakehealth.edu

Insurance Accepted »

Education & Training

  • M.D., University of Kansas , 1974
  • A.B., University of Kansas , 1970
  • Residency, Internal Medicine, Cincinnati General Hosp, 1977
  • Fellowship, Hematology And Oncology, University of Cincinnati, 1978
  • Fellowship, Hematology And Oncology, Tufts University School of Med, 1979
  • Fellowship, Molecular Genetics, Tufts University School of Med, 1981

Board Certifications

  • American Board of Internal Medicine, Internal Medicine, American Board of Internal Medicine

NPI Number

  • 1942370119
Christopher Y. Thomas, M.D.Wake Forest Baptist Health

Christopher Y. Thomas, M.D.

Associate Professor, Hematology & Oncology

Contact Information

Academic: 434-243-6356 | Department: 336-716-4464

Email: cythomas@wakehealth.edu

Recent Publications

Hollen PJ, Gralla RJ, Jones RA, Thomas CY, Brenin DR, Weiss GR, Schroen AT, Petroni GR. A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer. Support Care Cancer. 2013;21(3):889-899.

Dillon PM, Moskaluk C, Fracasso PM, Petroni GR, Thomas CY. Phase II study of dovitinib (TK1258) in patients with progressive metastatic adenoid cystic carcinoma [abstract]. J Clin Oncol. 2013;31(15 Suppl):6021.

Glisson BS, Tseng J, Marur S, Shin DM, Murphy BA, Cohen EEW, Thomas CY, Willey R, Cosaert J, William WN, Harun N, Lee JJ, Haddad RI. Randomized phase II trial of cixutumumab (CIX) alone or with cetuximab (CET) for refractory recurrent/metastatic squamous cancer of head and neck (R/M-SCCHN) [abstract]. J Clin Oncol. 2013;31(15 Suppl):6030.

Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Sun J, Koty PP, Kader AK, Cramer SD, Bova GS, Zheng SL, Gronberg H, Isaacs WB, Xu J. Genetic markers associated with early cancer-specific mortality following prostatectomy. Cancer. 2013;119(13):2405-2412.


Rahimi AS, Wilson DD, Saylor DK, Stelow EB, Thomas CY, Reibel JF, Levine PA, Shonka DC, Jameson MJ, Read PW. p16, Cyclin D1, and HIF-1alpha predict outcomes of patients with oropharyngeal squamous cell carcinoma treated with definitive intensity-modulated radiation therapy. Int J Otolaryngol. 2012;2012():685951.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Hematology & Oncology

Clinical Specialties

Genitourinary Oncology

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.